These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 3266064)

  • 21. Rewarming following hypothermic cardiopulmonary bypass in the malignant hyperthermia-susceptible patient: implications for diagnosis and perioperative management.
    Allen GC; Cattran CB
    Can J Anaesth; 1989 Jan; 36(1):81-5. PubMed ID: 2914339
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multiple anaesthetics for a malignant hyperthermia susceptible patient.
    Emmanuel ER
    Anaesthesia; 1988 Aug; 43(8):666-70. PubMed ID: 3421459
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics of dantrolene in an adult patient undergoing cardiopulmonary bypass.
    Comunale ME; DiNardo JA; Schwartz MJ
    J Cardiothorac Vasc Anesth; 1991 Apr; 5(2):153-5. PubMed ID: 1863728
    [No Abstract]   [Full Text] [Related]  

  • 24. Malignant hyperthermia following systemic rewarming after hypothermic cardiopulmonary bypass.
    Lichtman AD; Oribabor C
    Anesth Analg; 2006 Feb; 102(2):372-5. PubMed ID: 16428525
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sevoflurane Versus Total Intravenous Anesthesia for Isolated Coronary Artery Bypass Surgery With Cardiopulmonary Bypass: A Randomized Trial.
    Likhvantsev VV; Landoni G; Levikov DI; Grebenchikov OA; Skripkin YV; Cherpakov RA
    J Cardiothorac Vasc Anesth; 2016 Oct; 30(5):1221-7. PubMed ID: 27431595
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Anesthesia in a case of mitochondrial myopathy].
    Torres MD; Fernández-Esplá A; Baeza C; Torres C; Soler G
    Rev Esp Anestesiol Reanim; 1996 Mar; 43(3):114-5. PubMed ID: 8848637
    [No Abstract]   [Full Text] [Related]  

  • 27. Guidelines for the use of local anesthetics in the dental treatment of patients who are susceptible to malignant hyperthermia.
    D'Ambrosio J; Adragna MG
    Spec Care Dentist; 1988; 8(2):61-3. PubMed ID: 2978768
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [A case of high dose administration of propofol].
    Nishioka H; Kinuwaki H; Shimoda O; Terasaki H
    Masui; 2000 Oct; 49(10):1142-4. PubMed ID: 11075566
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Anesthetic management for a patient with Charcot-Marie-Tooth disease using propofol and nitrous oxide].
    Sugino S; Yamazaki Y; Nawa Y; Sato K; Sonoda H; Namiki A
    Masui; 2002 Sep; 51(9):1016-9. PubMed ID: 12382395
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Delayed Development of Malignant Hyperthermia Following Cardiopulmonary Bypass.
    Sams SH; Revilla S; Stahl DL
    Semin Cardiothorac Vasc Anesth; 2018 Mar; 22(1):95-99. PubMed ID: 28922985
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Propofol for anesthesia in a patient susceptible to malignant hyperthermia.
    Rosenberg MB
    Anesth Prog; 1991; 38(3):96-8. PubMed ID: 1839946
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Malignant hyperthermia and cardiac surgery.
    Aeschlimann N; Merino W; Lema G
    J Cardiothorac Vasc Anesth; 2009 Feb; 23(1):134-5. PubMed ID: 18834804
    [No Abstract]   [Full Text] [Related]  

  • 33. Case 4-2011: malignant hyperthermia in cardiac surgery.
    Leff JD; Duran H; Enriquez L; DeRose J; Shore-Lesserson L; Kim JH; Schwinn DA; Podgoreanu MV; Rosenberg H
    J Cardiothorac Vasc Anesth; 2011 Aug; 25(4):731-5. PubMed ID: 21420317
    [No Abstract]   [Full Text] [Related]  

  • 34. Propofol use in malignant hyperthermia: a case report.
    Freedman G; Sampson IH; Cagen S
    Mt Sinai J Med; 1993 Sep; 60(4):333-5. PubMed ID: 8232382
    [No Abstract]   [Full Text] [Related]  

  • 35. Management of otolaryngic patients susceptible to malignant hyperthermia without dantrolene.
    Derkay CS; Grundfast KM
    Otolaryngol Head Neck Surg; 1991 Nov; 105(5):680-6. PubMed ID: 1754251
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anesthesia in malignant hyperthermia susceptible patients.
    Mauritz W; Hackl W; Winkler M; Sporn P; Steinbereithner K
    Acta Anaesthesiol Belg; 1990; 41(2):87-94. PubMed ID: 1973553
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Continuous infusion propofol general anesthesia for dental treatment in patients with progressive muscular dystrophy.
    Kawaai H; Tanaka K; Yamazaki S
    Anesth Prog; 2005; 52(1):12-6. PubMed ID: 15859443
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Propofol and malignant hyperthermia susceptibility.
    Pollock AN; McKenzie AJ; Hodges M; Snoeck MM
    Anaesth Intensive Care; 1997 Oct; 25(5):583-5. PubMed ID: 9352778
    [No Abstract]   [Full Text] [Related]  

  • 39. More on anesthesia machines and malignant hyperpyrexia.
    Cooper JB; Philip JH
    Anesthesiology; 1989 Mar; 70(3):561-2. PubMed ID: 2923309
    [No Abstract]   [Full Text] [Related]  

  • 40. [An activated charcoal filter for eliminating volatile anesthetics. A contribution to the management of malignant hyperthermia].
    Jantzen JP; Eck J; Kleemann PP
    Anaesthesist; 1989 Nov; 38(11):639-41. PubMed ID: 2635839
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.